Skip to main content
Top
Published in: Dysphagia 1/2023

Open Access 19-05-2022 | Radiotherapy | Original Article

Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Authors: Stefano Ursino, Elisa Calistri, Francesca De Felice, Pierluigi Bonomo, Isacco Desideri, Pierfrancesco Franco, Francesca Arcadipane, Caterina Colosimo, Rosario Mazzola, Marta Maddalo, Alessandra Gonnelli, Giulia Malfatti, Riccardo Morganti, Daniela Musio, Fabiola Paiar

Published in: Dysphagia | Issue 1/2023

Login to get access

Abstract

Objectives

To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT.

Methods

MDADI questionnaires were collected at baseline and at 6 and 12 months after treatment. MDADI scores were categorized as follows: ≥ 80 “optimal,” 80–60 “adequate,” < 60 “poor” deglutition-related quality of life (QoL) group, and dichotomized as “optimal” vs “adequate/poor” for the analysis. A mean MDADI composite (MDADI-C) change of 10 points was considered as minimal clinically important difference (MCID).

Results

Sixty-three patients were enrolled of which 47 were considered for the analysis. At baseline, 26 (55%) were “optimal” and 21 (45%) were “adequate/poor.” The mean baseline MDADI-C score was 93.6 dropping to 81 at 6 months (p = 0.013) and slightly rising to 85.5 at 12 months (p = 0.321) for the “optimal” group. Indeed, the mean baseline MDADI-C score was 64.3 rising to 77.5 at 6 months (p = 0.006) and stabilizing at 76 at 12 months (p = 0.999) for the “adequate/poor” group. A statistically significant but not clinically relevant worsening of the MDADI-C score was reported for the “optimal” group, whereas both a statistically significant and clinically meaningful improvement of the MDADI-C score were reported for the “adequate/poor” group from before to post-treatment.

Conclusion

Our results suggest a doubly clinical benefit of dose optimization to SWOARs to minimize the RT sequalae in patients with a baseline “optimal” deglutition-related QoL and to recover from cancer dysphagia in those with a baseline “adequate/poor” deglutition-related QoL.
Appendix
Available only for authorised users
Literature
2.
go back to reference Pignon JP, Bourhis J, Domenge C, Designè L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet Lond Engl. 2000;355:949–55. https://doi.org/10.1016/S01406736(05)73666-7.CrossRef Pignon JP, Bourhis J, Domenge C, Designè L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet Lond Engl. 2000;355:949–55. https://​doi.​org/​10.​1016/​S01406736(05)73666-7.CrossRef
9.
go back to reference Chen AY, Frankowsky R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and validation of a dysphagia specific quality of life questionnaire for patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2001;127:870–6. Chen AY, Frankowsky R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and validation of a dysphagia specific quality of life questionnaire for patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2001;127:870–6.
11.
go back to reference Cartmill B, Cornwell P, Ward E, Davidson W, Porceddu S. A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia. 2012;27:32–45. https://doi.org/10.1007/s00455-011-9333-5.CrossRef Cartmill B, Cornwell P, Ward E, Davidson W, Porceddu S. A prospective investigation of swallowing, nutrition, and patient-rated functional impact following altered fractionation radiotherapy with concomitant boost for oropharyngeal cancer. Dysphagia. 2012;27:32–45. https://​doi.​org/​10.​1007/​s00455-011-9333-5.CrossRef
12.
go back to reference Lazarus CL, Husaini H, Hu K, Culliney B, Li Z, Urken M, Kacobson A, Persky M, Tran T, Concer C, Palacios C, Metcalfe-Klaw R, Kumar M, Bennet B, Harrison L. Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment. Dysphagia. 2014;29:365–75. https://doi.org/10.1007/s00455-014-9519-8.CrossRef Lazarus CL, Husaini H, Hu K, Culliney B, Li Z, Urken M, Kacobson A, Persky M, Tran T, Concer C, Palacios C, Metcalfe-Klaw R, Kumar M, Bennet B, Harrison L. Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment. Dysphagia. 2014;29:365–75. https://​doi.​org/​10.​1007/​s00455-014-9519-8.CrossRef
13.
go back to reference Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BH, Brandon Gunn G, Beadle BM, Rosenthal DI, Garden AS, Merill SK, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope. 2016;127:842–8. https://doi.org/10.1002/lary.26153.CrossRef Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BH, Brandon Gunn G, Beadle BM, Rosenthal DI, Garden AS, Merill SK, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope. 2016;127:842–8. https://​doi.​org/​10.​1002/​lary.​26153.CrossRef
15.
go back to reference Orlandi E, Miceli R, Infante G, Mirabile A, Alterio D, Cossu Rocca M, Denaro N, Vigna-Taglianti R, Merlotti A, Schindler A, Pizzorni N, Fallai C, Licitra L, Bossi P. Predictors of patient-reported dysphagia following IMRT plus chemotherapy in oropharyngeal cancer. Dysphagia. 2019;34:52–62. https://doi.org/10.1007/s00455-018-9913-8.CrossRef Orlandi E, Miceli R, Infante G, Mirabile A, Alterio D, Cossu Rocca M, Denaro N, Vigna-Taglianti R, Merlotti A, Schindler A, Pizzorni N, Fallai C, Licitra L, Bossi P. Predictors of patient-reported dysphagia following IMRT plus chemotherapy in oropharyngeal cancer. Dysphagia. 2019;34:52–62. https://​doi.​org/​10.​1007/​s00455-018-9913-8.CrossRef
16.
go back to reference Ursino S, D’Angelo E, Mazzola R, Merlotti A, Morganti R, Cristauda A, Paiar F, Musio D, Alterio D, Bacigalupo A, Russi EG, Lohr F. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy: a systematic review by the Italian head and neck radiotherapy study group. Strahlenther Onkol. 2017;193:877–89. https://doi.org/10.1007/s00066-017-1160-7.CrossRef Ursino S, D’Angelo E, Mazzola R, Merlotti A, Morganti R, Cristauda A, Paiar F, Musio D, Alterio D, Bacigalupo A, Russi EG, Lohr F. A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy: a systematic review by the Italian head and neck radiotherapy study group. Strahlenther Onkol. 2017;193:877–89. https://​doi.​org/​10.​1007/​s00066-017-1160-7.CrossRef
17.
go back to reference Eisbruch A, Hyungjin MK, Feng FY, Lyden TH, Haxer MJ, Feng M, Worden FP, Bradford CR, Prince ME, Moyer JS, Wolf GT, Chepeha DB, Haken RKT. Chemo-IMRT of oropharymgeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys. 2011;8:e93–9. https://doi.org/10.1016/j.ijrobp.2010.12.067.CrossRef Eisbruch A, Hyungjin MK, Feng FY, Lyden TH, Haxer MJ, Feng M, Worden FP, Bradford CR, Prince ME, Moyer JS, Wolf GT, Chepeha DB, Haken RKT. Chemo-IMRT of oropharymgeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys. 2011;8:e93–9. https://​doi.​org/​10.​1016/​j.​ijrobp.​2010.​12.​067.CrossRef
18.
go back to reference Christianen M, Van der Schaaf A, Van der Laan H, Verdonck-de Leeuw I, Doornaert P, Chouvalova O, Steenbakkers RJHM, Leemas CR, Osting SF, Van Der Laan BFAM, Roodenburg JLN, Slotman BJ, Bijl H, Langendijk JA. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach. Radiother Oncol. 2016;118:298–303. https://doi.org/10.1016/j.radonc.2015.11.009.CrossRef Christianen M, Van der Schaaf A, Van der Laan H, Verdonck-de Leeuw I, Doornaert P, Chouvalova O, Steenbakkers RJHM, Leemas CR, Osting SF, Van Der Laan BFAM, Roodenburg JLN, Slotman BJ, Bijl H, Langendijk JA. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach. Radiother Oncol. 2016;118:298–303. https://​doi.​org/​10.​1016/​j.​radonc.​2015.​11.​009.CrossRef
19.
go back to reference Merlotti A, Alterio D, Vigna Taglianti R, Muraglia A, Lastrucci L, Manzo R, Gambaro G, Caspiani O, Miccichè F, Deodato F, Pergolizzi S, Franco P, Corvò R, Russi EG, Sanguineti G. Technical guidelines for head and neck cancer on behalf of the Italian association of radiation oncology-head and neck working group. Radiat Oncol. 2014;29(9):264. https://doi.org/10.1186/s13014-014-0264-9.CrossRef Merlotti A, Alterio D, Vigna Taglianti R, Muraglia A, Lastrucci L, Manzo R, Gambaro G, Caspiani O, Miccichè F, Deodato F, Pergolizzi S, Franco P, Corvò R, Russi EG, Sanguineti G. Technical guidelines for head and neck cancer on behalf of the Italian association of radiation oncology-head and neck working group. Radiat Oncol. 2014;29(9):264. https://​doi.​org/​10.​1186/​s13014-014-0264-9.CrossRef
21.
go back to reference Schindler A, Borghi E, Tiddia C, Ginocchio D, Felisati G, Ottaviani F. Adaptation and validation of the Italian MD Anderson dysphagia inventory (MDADI). Rev Laryngol Otol Rhinol. 2008;129:97–100. Schindler A, Borghi E, Tiddia C, Ginocchio D, Felisati G, Ottaviani F. Adaptation and validation of the Italian MD Anderson dysphagia inventory (MDADI). Rev Laryngol Otol Rhinol. 2008;129:97–100.
23.
go back to reference Lazarus CL, Husaini H, Hu K, Culliney B, Li Z, Urken M, Jacobson A, Persky M, Tran T, Concert C, Palacios D, Metcalfe-Klaw R, Kumar M, Bennet B, Harrison L. Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment. Dysphagia. 2014;29:365–75. https://doi.org/10.1007/s00455-014-9519-8.CrossRef Lazarus CL, Husaini H, Hu K, Culliney B, Li Z, Urken M, Jacobson A, Persky M, Tran T, Concert C, Palacios D, Metcalfe-Klaw R, Kumar M, Bennet B, Harrison L. Functional outcomes and quality of life after chemoradiotherapy: baseline and 3 and 6 months post-treatment. Dysphagia. 2014;29:365–75. https://​doi.​org/​10.​1007/​s00455-014-9519-8.CrossRef
25.
go back to reference Jovanovic N, Dreyer C, Hawkins S, Thouless K, Palma D, Doyle PC, Theurer JA. The natural history of weight and swallowing outcomes in oropharyngeal cancer patients following radiation or concurrent chemoradiation therapy. Support Care Cancer. 2021;29:1597–607. Jovanovic N, Dreyer C, Hawkins S, Thouless K, Palma D, Doyle PC, Theurer JA. The natural history of weight and swallowing outcomes in oropharyngeal cancer patients following radiation or concurrent chemoradiation therapy. Support Care Cancer. 2021;29:1597–607.
26.
go back to reference Roe JWG, Drinnan MJ, Carding PN, Harrington KJ, Nutting CM. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia? Oral Oncol. 2014;50:1182–7. Roe JWG, Drinnan MJ, Carding PN, Harrington KJ, Nutting CM. Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer. How important is dysphagia? Oral Oncol. 2014;50:1182–7.
27.
go back to reference Grant SR, Hutcheson KA, Ye R, Garden AS, Morrison WH, Rosenthal DI, Gunn GB, Fuller CD, Phan J, Reddy JP, Moreno AC, Lewin JS, Sturgis EM, Ferrarotto R, Frank SJ. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother Oncol. 2020;148:133–9. Grant SR, Hutcheson KA, Ye R, Garden AS, Morrison WH, Rosenthal DI, Gunn GB, Fuller CD, Phan J, Reddy JP, Moreno AC, Lewin JS, Sturgis EM, Ferrarotto R, Frank SJ. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother Oncol. 2020;148:133–9.
28.
go back to reference Ursino S, Giuliano A, DiMartino F, Cocuzza P, Molinari A, Stefanelli A, Giusti P, Aringhieri G, Morganti R, Neri E, Traino C, Paiar F. Incorporating dose–volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy. Strahlenther Onkol. 2021;197:209–18. https://doi.org/10.1007/s00066-020-01697-7.CrossRef Ursino S, Giuliano A, DiMartino F, Cocuzza P, Molinari A, Stefanelli A, Giusti P, Aringhieri G, Morganti R, Neri E, Traino C, Paiar F. Incorporating dose–volume histogram parameters of swallowing organs at risk in a videofluoroscopy-based predictive model of radiation-induced dysphagia after head and neck cancer intensity-modulated radiation therapy. Strahlenther Onkol. 2021;197:209–18. https://​doi.​org/​10.​1007/​s00066-020-01697-7.CrossRef
33.
go back to reference Schindler A, Denaro N, Russi EG, Pizzorni N, Bossi P, Merlotti A, Spadola Bissetti M, Numico G, Gava A, Orlandi E, Caspiani O, Buglione M, Alterio D, Bacigalupo A, De Sanctis V, Pavanato G, Ripamonti C, Merlano M, Licitra L, Sanguineti G, Langendijk JA, Murphy B. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus. Crit Rev Oncol Hematol. 2015;96:372–84. https://doi.org/10.1016/j.critrevonc.2015.06.005.CrossRef Schindler A, Denaro N, Russi EG, Pizzorni N, Bossi P, Merlotti A, Spadola Bissetti M, Numico G, Gava A, Orlandi E, Caspiani O, Buglione M, Alterio D, Bacigalupo A, De Sanctis V, Pavanato G, Ripamonti C, Merlano M, Licitra L, Sanguineti G, Langendijk JA, Murphy B. Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: literature review and consensus. Crit Rev Oncol Hematol. 2015;96:372–84. https://​doi.​org/​10.​1016/​j.​critrevonc.​2015.​06.​005.CrossRef
Metadata
Title
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Authors
Stefano Ursino
Elisa Calistri
Francesca De Felice
Pierluigi Bonomo
Isacco Desideri
Pierfrancesco Franco
Francesca Arcadipane
Caterina Colosimo
Rosario Mazzola
Marta Maddalo
Alessandra Gonnelli
Giulia Malfatti
Riccardo Morganti
Daniela Musio
Fabiola Paiar
Publication date
19-05-2022
Publisher
Springer US
Published in
Dysphagia / Issue 1/2023
Print ISSN: 0179-051X
Electronic ISSN: 1432-0460
DOI
https://doi.org/10.1007/s00455-022-10434-4

Other articles of this Issue 1/2023

Dysphagia 1/2023 Go to the issue